Uncategorized
Presbyopia Therapeutics Pipeline Analysis 2018 – Clinical Trials & Results, Patents, Designations, Collaborations and Other Developments – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Presbyopia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations and Other Developments" report has been added to ResearchAndMarkets.com's offering. The study analyzed that the presbyopia therapeutics pipeline comprises nine drug candidates in different stages of development. Presbyopia is an age-related eye condition that causes visual impairment gradually. The disease has been described as "an irreversible opt